Director of Benefits, Tidewater Utilities
Oscar Delaney· Director of Benefits, Lumen Biosciences
Asked in Global & Mobility ·
We have 310 employees in Istanbul and Izmir, part of a pharmaceuticals group of about 18,000. For the last two years we have run a main review in January and an interim one in July. This year the January increase was 38% on average and people were asking about July before the letters had gone out.
Group finance wants to return to one review a year and absorb the rest through a one-off payment. Local management says we will lose our sales force if we do.
What cadence are others on, and is anyone using lump sums rather than base increases for the mid-year step?
1 helpful · 5 replies · 15 views · 5 following